Efficacy and Safety of Dexmedetomidine to Bupivacaine in Supraclavicular Brachial Plexus Block

• Status: Completed
• Trial end date: 2024-03-11
• Target enrollment: 0
• Participant gender: All

Summary

The study aims to evaluate the analgesic efficacy and safety of addition of 1µg/kg dexmedetomidine to 20ml bupivacaine compared to 20ml and 30ml bupivacaine without additives in ultrasound-guided supraclavicular brachial plexus block for anesthesia.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Kafrelsheikh University
• Treatments: Bupivacaine; Dexmedetomidine

Criteria

Inclusion Criteria:

• American Society of Anesthesiologist (ASA) grade I or II patients

• both sexes

• scheduled for elective upper limb surgery below mid-humerus level under Ultrasound -guided Supraclavicular brachial plexus block .

Exclusion Criteria:

• with pre-existing peripheral neuropathy of upper limb.

• Bleeding disorders.

• Infection at injection site.

• Untreated pneumothorax.

• Patients on adrenoreceptor agonist or antagonist therapy.

• History of severe cardiac,.respiratory, hepatic, or renal disease.

• pregnancy and known hypersensitivity to the study drugs.